Oxidative stress in chronic obstructive pulmonary disease

American Journal of Respiratory and Critical Care Medicine

Volumn 156, Issue 2 I, 1997, Pages 341-357

  Repine, John E ^a   Bast, Aalt ^b   Lankhorst, Ida ^b  

^a Webb Waring Antioxidant Res I   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; ANTIOXIDANT; CORTICOSTEROID;

ANTIOXIDANT ACTIVITY; CHRONIC OBSTRUCTIVE LUNG DISEASE; DNA DAMAGE; HUMAN; INFLAMMATION; OXIDATIVE STRESS; PATHOPHYSIOLOGY; PRIORITY JOURNAL; REVIEW; SMOKING;

EID: 0030752487     PISSN: 1073449X     EISSN: None     Source Type: Journal    
DOI: 10.1164/ajrccm.156.2.9611013     Document Type: Review

References (296)

1. ATS Statement. 1995. Standards for the diagnosis and care of patients with chronic obstructive pulmonary disease. Am. J. Respir. Crit. Care Med. 152(Suppl.):S77-S121.
2. Siafakas, N. M., P. Vermeire, N. B. Pride, P. Paoletti, J. Gibson, P. Howard, J. C. Yernault, M. DeCramer, T. Higgenbottom, D. S. Postma, and J. Rees. 1995. Optimal assessment and management of chronic obstructive pulmonary disease (COPD): a consensus statement of the European Respiratory Society (ERS). Eur. Respir. J. 8:1398-1420.
3. Heffner, J. A., and J. E. Repine. 1989. State of the art: pulmonary strategies of antioxidant defense. Am. Rev. Respir. Dis. 140:531-554.
4. Halliwell, B. 1996. Antioxidants in human health and disease. Ann. Rev. Nutr. 16:33-50.
5. Cantin, A. M., and R. G. Crystal. 1985. Oxidants, antioxidants and the pathogenesis of emphysema. Eur. J. Respir. Dis. 66:7-17.
6. Church, D. F., and W. A. Pryor. 1991. The oxidative stress placed on the lung by cigarette smoke. In R. G. Crystal and J. B. West, editors. The Lung: Scientific Foundations. Raven Press, New York. 1971-1979.
7. Fletcher, C., and N. B. Pride. 1984. Definitions of emphysema, chronic bronchitis, asthma, and airflow obstruction: 25 years on from the Ciba symposium. Thorax 39:81-85.
8. Vermeire, P. 1993. Differential diagnosis in asthma and chronic obstructive pulmonary disease. In N. J. Gross, editor. Anticholinergic Therapy in Obstructive Airways Disease. Franklin Scientific Publ. 48-60.
9. Vermeire, P. A., and N. B. Pride. 1991. A splitting look at chronic non-specific lung disease (CNSLD): common features but diverse pathogenesis. Eur. Respir. J. 4:490-496.
10. Feinleib, M., H. M. Rosenberg, J. G. Collins, J. E. Delozier, R. Pokras, and F. M. Chevarley. 1989. Trends in COPD morbidity and mortality in the United States. Am. Rev. Respir. Dis. 140:9-18.
11. Edelman, N. H., R. M. Kaplan, A. S. Buist, A. B. Cohen, L. A. Hoffman, M. E. Kleinhenz, G. L. Snider, and F. E. Speizer. 1992. Chronic obstructive pulmonary disease: task force on research and education for the prevention of control of respiratory diseases. Chest 102:243-256.
12. Snider, G. L. 1989. Chronic obstructive pulmonary disease: risk factors, pathophysiology, and pathogenesis. Ann. Rev. Med. 40:411-429.
13. Peto, R., A. D. Lopez, J. Boreham, M. Thun, and C. Heatch. 1992. Mortality from tobacco in developed countries: indirect estimation from national vital statistics. Lancet 339:1268-1278.
14. Oxman, A. D., D. C. F. Muir, H. S. Shannon, S. R. Stock, E. Hnizdo, and H. J. Lange. 1993. Occupational dust exposure and chronic obstructive pulmonary disease. Am. Rev. Respir. Dis. 148:38-48.
15. Bast, A., G. R. M. M. Haenen, and C. J. A. Doelman. 1991. Oxidants and antioxidants: state of the art. Am. J. Med. 91:2-13.
16. Thompson, A. B., T. Bohling, A. Heires, J. Linder, and S. I. Rennard. 1991. Lower respiratory tract iron burden is increased in association with cigarette smoking. J. Lab. Clin. Med. 117:494-499.
17. Nelson, M. E., A. R. O'Brien-Ladner, and L. J. Wesselius. 1996. Regional variation in iron and iron-binding proteins within the lungs of smokers. Am. J. Respir. Crit. Care Med. 152:1353-1358.
18. U.S. Public Health Service. 1979. Smoking and Health: A Report of the Surgeon General. U.S. Government Printing Office, Washington, DC. DHEW Publication No. 79-50066.
19. Cook, J. D., C. A. Finch, and N. J. Smith. 1976. Evaluation of the iron status of a population. Blood 48:449-455.
20. Wesselius, L. J., M. E. Nelson, and B. S. Skikne. 1994. Increased release of ferritin and iron by iron loaded alveolar macrophages in cigarette smokers. Am. J. Respir. Crit. Care Med. 150:690-695.
21. Qian, M. W., and J. W. Eaton. 1991. Iron translocation by free fatty acids. Am. J. Pathol. 139:1425-1434.
22. Qian, M. W., and J. W. Eaton. 1994. Free fatty acids enhance hypochlorous acid production by activated neutrophils. J. Lab. Clin. Med. 124: 86-95.
23. Gladston, M., J. G. Feldman, V. Levytska, and B. Magnussen. 1987. Antioxidant activity of serum ceruloplasmin and transferrin available iron-binding capacity in smokers and nonsmokers. Am. Rev. Respir. Dis. 135:783-787.
24. Lapenna, D., S. De Gioia, A. Mezzetii, G. Ciofani, A. Consoli, L. Marzio, and F. Cuccurullo. 1995. Cigarette smoke, ferritin, and lipid peroxidation. Am. J. Respir. Crit. Care Med. 151:431-435.
25. Moreno, J. J., M. Foroozesh, D. F. Church, and W. A. Pryor. 1992. Release of iron from ferritin by aqueous extracts of cigarette smoke. Chem. Res. Toxicol. 5:116-123.
26. Cantin, A. M., S. L. North, G. A. Fells, R. C. Hubbard, and R. G. Crystal. 1987. Oxidant-mediated epithelial cell injury in idiopathic pulmonary fibrosis. J. Clin. Invest. 79:1665-1673.
27. Cantin, A. M., S. L. North, R. C. Hubbard, and R. G. Crystal. 1989. Normal alveolar epithelial lining fluid contains high levels of glutathione. J. Appl. Physiol. 63:152-157.
28. Laurell, C. B., and S. Ericksson. 1963. The electrophoretic alpha-globulin pattern of serum in alpha-1-antitrypsin deficiency. Scand. J. Clin. Invest. 15:132-140.
29. Fujita, J., N. L. Nelson, D. M. Daughton, C. A. Dobry, J. R. Spurzem, S. Irino, and S. J. Rennard. 1990. Evaluation of elastase and anti-elastase balance in patients with chronic bronchitis and pulmonary emphysema. Am. Rev. Respir. Dis. 142:57-62.
30. Janoff, A. 1983. Biochemical links between cigarette smoking and pulmonary emphysema. J. Appl. Physiol. 55:285-293.
31. Janoff, A. 1985. Elastases and emphysema: current assessment of the protease-antiprotease hypothesis. Am. Rev. Respir. Dis. 132:417-433.
32. Shapiro, S. D. 1995. The pathogenesis of emphysema: the elastase: anti-elastase hypothesis 30 years later. Proceedings of the Assoc. Amer. Phys. 107:346-352.
33. Pryor, W. A., M. D. Dooley, and D. F. Church. 1986. The mechanisms of inactivation of human alpha-1-proteinase inhibitor by gas phase cigarette smoke. Free Radic. Biol. Med. 2:161-168.
34. Hubbard, R. C., F. Ogushi, G. A. Fells, A. M. Cantin, S. Jallat, M. Courtnery, and R. G. Crystal. 1987. Oxidants spontaneously released by alveolar macrophages of cigarette smokers can inactivate the active site of alpha 1-antitrypsin, rendering it ineffective as an inhibitor of neutrophil elastase. J. Clin. Invest. 80:1289-1295.
35. 1-proteinase inhibitor by alveolar inflammatory cells from smoking patients with or without emphysema. Am. Rev. Respir. Dis. 147:1537-1543.
36. Wallaert, B., A. Certs, B. Gressier, P. Gosset, and C. Voisen. 1993. Oxidative inactivation of α-1-proteinase inhibitor by alveolar epithelial type II cells. J. Appl. Physiol. 75:2376-2382.
37. Carp, H., F. Miller, J. R. Hoidal, and A. Janoff. 1982. Potential mechanism of emphysema: alpha-1-proteinase inhibitor recovered from lungs of cigarette smokers contains oxidized methionine and has decreased elastase inhibitor capacity. Proc. Natl. Acad. Sci. U.S.A. 79: 2041-2045.
38. Maier, K. L., L. Leuschel, and U. Constabel. 1992. Increased oxidized methionine residues in BAL fluid proteins in acute or chronic bronchitis. Eur. Respir. J. 5:651-658.
39. Baird, B. R., J. C. Cheronis, R. A. Sandhaus, E. M. Berger, C. W. White, and J. E. Repine. 1986. Oxygen metabolites and neutrophil elastase synergistically cause edematous injury in isolated rat lungs. J. Appl. Physiol. 61:2224-2229.
40. Janoff, A., B. Sloan, and G. Weinbaum. 1977. Experimental emphysema induced with purified human neutrophil elastase: tissue localization of the instilled protease. Am. Rev. Respir. Dis. 115:461.
41. Senior, R. M., H. Tegner, C. Kuhn, K. Ohlsson, B. C. Starcher, and J. A. Pierce. 1977. The induction of pulmonary emphysema induced with human leukocyte elastase. Am. Rev. Respir. Dis. 116:469-475.
42. Snider, G., L. E. C. Lucey, T. G. Christensen, P. J. Stone, J. D. Calore, A. Catanese, and C. Franzblau. 1984. Emphysema and bronchial secretory cell metaplasia induced in hamsters by human neutrophil products. Am. Rev. Respir. Dis. 129:155-160.
43. Kao, R. C., N. G. Wehner, K. M. Skubitz, B. H. Gray, and J. R. Hoidal. 1988. Proteinase 3: a distinct human polymorphonuclear leukocyte proteinase that produces emphysema in hamsters. J. Clin. Invest. 82:1963-1973.
44. Kramps, J. A., C. van Twisk, and D. H. Digkman. 1988. Oxidative inactivation of antileukoprotease is triggered by polymorphonuclear leukocytes. Clin. Sci. 75:53-62.
45. Laurent, P., A. Janoff, and H. M. Kagan. 1983. Cigarette smoke blocks cross-linking of elastin in vitro. Am. Rev. Respir. Dis. 127:189-192.
46. Adler, K. B., W. J. Holden-Stauffer, and J. E. Repine. 1990. Oxygen metabolites stimulate release of high molecular weight glycoconjugates by cell and organ cultures of rodent respiratory epithelium via an arachidonic acid-dependent mechanism. J. Clin. Invest. 85:75-85.
47. Feldman, C., R. Anderson, K. Kanthakumar, A. Vargas, P. J. Cole, and R. Wilson. 1994. Oxidant-mediated ciliary dysfunction. Free Radic. Biol. Med. 17:1-10.
48. Tate, R. M., H. G. Morris, W. R. Schroeder, and J. E. Repine. 1984. Oxygen metabolites stimulate thromboxane production and vasoconstriction in isolated saline-perfused rabbit lungs. J. Clin. Invest. 74:608-613.
49. 2 metabolites inhibit surfactant metabolism. Am. J. Physiol. 259:328-334.
50. Barrows, S., P. Ward, M. Sleightholm, J. Ritter, and C. Dollery. 1979. Cigarette smoking: profiles of thromboxane- and prostacyclin-derived products in human urine. Biochim. Biophys. Acta 993:121-127.
51. Jones, J. G., P. Lawler, J. C. W. Crawler, B. D. Mintz, G. Hulands, and N. Veall. 1980. Increased alveolar epithelial permeability in cigarette smokers. Lancet 1:66-68.
52. Li, X. Y., K. Donaldson, I. Rahman, and W. MacNee. 1994. An investigation of the role of glutathione in the increased epithelial permeability induced by cigarette smoke in vivo and in vitro. Am. J. Respir. Crit. Care Med. 149:1518-1525.
53. Tsuchiya, M., D. F. Thompson, Y. J. Suzuki, C. E. Cross, and L. Parker. 1992. Superoxide formed from cigarette smoke impairs polymorphonuclear leukocyte active oxygen generation activity. Arch. Biochem. Biophys. 299:30-37.
54. Noronha-Dutra, A. A., M. M. Epperlein, and N. Woolf. 1993. Effect of cigarette smoking on cultured human endothelial cells. Cardiovasc. Res. 27:774-778.
55. Linden, M., J. B. Rasmussen, E. Piitulainen, A. Tunek, M. Larson, H. Tegner, P. Venge, L. A. Laitinen, and R. Brattsand. 1993. Airway inflammation in smokers with nonobstructive and obstructive chronic bronchitis. Am. Rev. Respir. Dis. 148:1226-1232.
56. Jordan, J., S. Wan, C. Gairola, and D. St. Clair. 1993. Protective role of manganese superoxide dismutase in cigarette smoke-induced cytotoxicity (abstract). Proceedings of the Annual Meeting of the American Association of Cancer Researchers 34:A97.
57. Pryor, W. A., and K. Stone. 1993. Oxidants in cigarette smoke: radicals, hydrogen peroxides, peroxynitrate, and peroxynitrite. Ann. N.Y. Acad. Sci. 686:12-28.
58. Church, D. F., and W. A. Pryor. 1985. Free-radical chemistry of cigarette smoke and its toxicological implications. Environ. Health Perspect. 64:111-126.
59. Pryor, W. A., D. G. Prier, and D. F. Church. 1983. Electron-spin resonance study of mainstream and sidestream cigarette smoke: nature of free radicals in gas-phase smoke and cigarette tar. Environ. Health Perspect. 47:345-355.
60. Church, D. F., T. J. Burkey, and W. A. Pryor. 1990. Preparation of human lung tissue from cigarette smokers for analysis by electron spin resonance spectroscopy. Methods Enzymol. 168:665-669.
61. Bluhm, A. L., J. Weinstein, and J. A. Sousa. 1971. Free radicals in tobacco smoke. Nature 229:500.
62. Zang, L. Y., K. Stone, and W. A. Pryor. 1995. Detection of free radicals in aqueous extracts of cigarette tar by electronspin resonance. Free Radic. Biol. Med. 19:161-167.
63. Eiserich, J. P., V. Vossen, C. A. O'Neill, B. Halliwell, C. E. Cross, and A. van der Vliet. 1994. Molecular mechanisms of damage by excess nitrogen oxides: nitration of tyrosine by gas-phase cigarette smoke (abstract). FEBS Lett. 353:53-56.
64. Wurzel, H., C. C. Yeh, C. Gairola, and C. K. Chow. 1995. Oxidative damage and antioxidant status in the lungs and bronchoalveolar lavage fluid of rats exposed chronically to cigarette smoke. Journal of Biochemical Toxicology 10:11-17.
65. Zhou, C., B. Gilks, A. Churg, and J. L. Wright. 1996. Exposure to cigarette smoke causes rapid upregulation of pulmonary nitric oxide synthetase (abstract). Am. J. Respir. Crit. Care Med. 153:A734.
66. Weitberg, A. B., and D. Converse. 1993. Oxygen radicals potentiate the genetic toxicity of tobacco-specific nitrosamines. Clin. Genet. 43:88-91.
67. Jeffery, P. K. 1991. Morphology of the airway wall in asthma and in chronic obstructive pulmonary disease. Am. Rev. Respir. Dis. 143:1152-1158.
68. Adesina, A. M., V. Vallyathan, E. N. McQuillen, S. O. Weaver, and J. E. Craighead. 1991. Bronchiolar inflammation and fibrosis associated with smoking. Am. Rev. Respir. Dis. 143:144-149.
69. Ollerenshaw, S. L., and A. J. Woolcock. 1992. Characteristics of inflammation in biopsies from large airways of subjects with asthma and subjects with chronic airflow limitation. Am. Rev. Respir. Dis. 145:922-927.
70. Martin, T. R., G. Raghu, R. J. Maunder, and S. C. Springmeyer. 1985. The effects of chronic bronchitis and chronic air-flow obstruction on lung cell populations recovered by bronchoalveolar lavage. Am. Rev. Respir. Dis. 132:254-260.
71. Eidelman, D., M. P. Saetta, H. G. Nai-San Wang, J. R. Hoidal, M. King, and M. G. Cosio. 1990. Cellularity of the alveolar walls in smokers and its relation to alveolar destruction. Am. Rev. Respir. Dis. 141:1547-1552.
72. Merchant, R. K., D. A. Schwartz, R. A. Helmers, C. S. Dayton, and G. W. Hunninghake. 1992. Bronchoalveolar lavage cellularity. Am. Rev. Respir. Dis. 146:488-453.
73. Dunnill, M. S., G. R. Massarella, and J. A. Anderson. 1969. A comparison of the quantitative anatomy of the bronchi in normal subjects, in status asthmaticus, in chronic bronchitis, and in emphysema. Thorax 69:39-42.
74. Wright, J. L., J. E. Hobson, B. Wiggs, P. D. Pare, and J. C. Hogg. 1988. Airway inflammation and peribronchiolar attachments in the lungs of nonsmokers, current and ex-smokers. Lung 166:277-286.
75. Wiggs, B. R., C. Bosken, P. D. Paré, A. James, and J. C. Hogg. 1992. A model of airway narrowing in asthma and in chronic obstructive pulmonary disease. Am. Rev. Respir. Dis. 145:1251-1258.
76. Hobson, J. E., J. L. Wright, B. R. Wiggs, and J. C. Hogg. 1986. Comparison of the cell content of lung lavage fluid with the presence of emphysema and peripheral airways inflammation in resected lungs. Respiration 50:1-8.
77. Matsuba, K., J. L. Wright, B. R. Wiggs, P. D. Paré, and J. C. Hogg. 1989. The changes in airways structure associated with reduced forced expiratory volume in one second. Eur. Respir. J. 2:834-839.
78. Niewoehner, D. E., J. Kleinerman, and D. B. Rice. 1974. Pathologic changes in the peripheral airways of young cigarette smokers. N. Engl. J. Med. 291:755-758.
79. Saetta, M., A. Stefano, P. Maestrelli, A. Ferraresso, R. Drigo, A. Potena, A. Ciaccia, and L. M. Fabbri. 1993. Activated T-lymphocytes and macrophages in bronchial mucosa of subjects with chronic bronchitis. Am. Rev. Respir. Dis. 147:301-306.
80. Glynn, A. A., and L. Michaels. 1960. Bronchial biopsy in chronic bronchitis and asthma. Thorax 15:142-153.
81. Fournier, M., F. Lebargy, F. Le Roy Ladurie, E. Lenormand, and R. Pariente. 1989. Intraepithelial T-lymphocyte subsets in the airways of normal subjects and of patients with chronic bronchitis. Am. Rev. Respir. Dis. 140:737-742.
82. Salvato, G. 1968. Some histological changes in chronic bronchitis and asthma. Thorax 23:168-172.
83. Bosken, C. H., J. Hards, K. Gatter, and J. C. Hogg. 1992. Characterization of the inflammatory reaction in the peripheral airways of cigarette smokers using immunocytochemistry. Am. Rev. Respir. Dis. 145:911-917.
84. Kilburn, K. H., and W. McKenzie. 1975. Leucocyte recruitment to airways by cigarette smoke and particle phase in contrast to cytotoxicity of vapor. Science 189:634-637.
85. Wright, J. L., J. Hobson, B. R. Wiggs, and J. C. Hogg. 1988. Comparison of inflammatory cells in bronchoalveolar fluid with those in the lumen and tissue peripheral airways and alveolar airspace. Lung 166:75-83.
86. Hunninghake, G. W., and R. G. Crystal. 1983. Cigarette smoking and lung destruction: accumulation of neutrophils in lungs of cigarette smokers. Am. Rev. Respir. Dis. 128:833-838.
87. MacNee, W., B. Wiggs, A. S. Belzberg, and J. C. Hogg. 1989. The effect of cigarette smoking on neutrophil kinetics in human lungs. N. Engl. J. Med. 321:924-928.
88. Drost, E. M., C. Selby, S. Lannan, G. D. Lowe, and W. MacNee. 1992. Changes in neutrophil deformity following in vitro smoke exposure: mechanisms and protection. Am. J. Respir. Cell Mol. Biol. 6:287-295.
89. Selby, C., E. Drost, S. Lannan, P. K. Wraith, and W. MacNee. 1991. Neutrophil retention in the lungs of patients with chronic obstructive pulmonary disease. Am. Rev. Respir. Dis. 143:1359-1364.
90. Lehr, H. A., E. Kress, M. D. Menger, H. P. Friedl, C. Hubner, K. E. Arfors, and K. Messner. 1993. Cigarette smoke elicits leukocyte adhesion to endothelium in hamsters: inhibition by CuZn-SOD. Free Radic. Biol. Med. 14:573-581.
91. Klut, M. E., C. M. Doerschuk, J. C. Hogg, S. F. Vaneedow, and A. R. Burns. 1993. Activation of neutrophils within pulmonary microvessels of rabbits exposed to cigarette smoke. Am. J. Respir. Cell Mol. Biol. 9:82-90.
92. Di Stefano, A., P. Maestrelli, A. Roggeri, G. Turato, S. Calabro, A. Potena, C. E. Mapp, A. Ciaccia, L. Covacev, L. M. Fabbri, and M. Saetta. 1994. Upregulation of adhesion molecules in the bronchial mucosa of subjects with chronic obstructive bronchitis. Am. J. Respir. Crit. Care Med. 149:803-810.
93. Riise, G. C., S. Larsson, C. G. Lofdahl, and B. A. Andersson. 1994. Circulating cell adhesion molecules in bronchial lavage and serum in COPD patients with chronic bronchitis. Eur. Respir. J. 7:1673-1677.
94. Baluk, P., C. Bertrand, P. Geppetti, D. M. McDonald, and J. A. Nadel. 1996. NKK1 receptor antagonist CP-99,994 inhibits cigarette smoke-induced neutrophil and eosinophil adhesion in rat tracheal venules. Exp. Lung Res. 22:409-418.
95. Yamamoto, C., T. Yoneda, M. Yoshikawa, A. Fu, H. Takenaka, T. Tokuyama, Y. Okamoto, K. Tomoda, M. Nakaya, A. Kobayashi, K. Tsukaguchi, and N. Narita. 1996. Airway inflammation in chronic obstructive pulmonary disease is mediated by interleukin-8 (abstract). Am. J. Respir. Crit. Care Med. 153:A821.
96. Shoji, S., R. F. Ertl, S. Koyama, R. Robbins, G. Leikauf, S. V. Essen, and S. I. Renard. 1995. Cigarette smoke stimulates release of neutrophil chemotactic activity from cultured bovine bronchial epithelial cells. Clin. Sci. 88:337-344.
97. Keatings, V. M., P. D. Collins, D. M. Scott, and P. J. Barnes. 1996. Differences in interleukin-8 and tumor necrosis factor-α in induced sputum from patients with chronic obstructive pulmonary disease or asthma. Am. J. Respir. Crit. Care Med. 153:530-534.
98. 4 levels in patients with obstructive pulmonary disease. Chest 99:289-291.
99. Totti, N., K. T. McCusker, E. J. Campbell, G. L. Griffin, and R. M. Senior. 1984. Nicotine is chemotactic for neutrophils and enhances neutrophil responsiveness to chemotactic peptides. Science 13:169-171.
100. Aoshiba, K., A. Nagai, and K. Konno. 1994. Nicotine prevents a reduction in neutrophil filterability induced by cigarette smoke exposure. Am. J. Respir. Crit. Care Med. 150:1101-1107.
101. Aoshiba, K., A. Nagai, S. Yasui, and K. Konno. 1996. Nicotine prolongs neutrophil survival by suppressing apoptosis. J. Lab. Clin. Med. 127:186-194.
102. Ludwig, P. W., and J. R. Hoidal. 1982. Alterations in leukocyte oxidative metabolism in cigarette smokers. Am. Rev. Respir. Dis. 126:977-980.
103. Burnett, D., A. Chamba, S. L. Hill, and R. A. Stockley. 1987. Neutrophils from subjects with chronic obstructive lung disease show enhanced chemotaxis and extracellular proteolysis. Lancet 2:1043-1046.
104. Bridges, R. B., M. C. Fu, and S. R. Rehm. 1985. Increased neutrophil myeloperoxidase activity associated with cigarette smoking. Eur. J. Respir. Dis. 67:84-93.
105. Anderson, R., A. J. Theron, G. A. Richards, M. S. Myers, and A. J. V. Rensbury. 1991. Passive smoking by humans sensitizes circulating neutrophils. Am. Rev. Respir. Dis. 144:570-574.
106. Postma, D. S., T. E. J. Renkema, J. A. Noordhoek, H. Faber, H. J. Sluiter, and H. Kauffman. 1988. Association between non-specific bronchial hyperreactivity and superoxide anion production by polymorphonuclear leukocytes in chronic airflow obstruction. Am. Rev. Respir. Dis. 137:57-61.
107. Rahman, I., and W. MacNee. 1996. Oxidant/antioxidant imbalance in smokers and chronic obstructive pulmonary disease. Thorax 51:348-350.
108. Brown, D., G. Brown, J. H. Williams, and W. MacNee. 1993. Priming of neutrophils sequestered in the pulmonary vasculature in acute alveolitis. Am. Rev. Respir. Dis. 144:668.
109. Rasp, F. L., C. C. Clawson, J. R. Hoidal, and J. E. Repine. 1978. Reversible impairment of the adherence of alveolar macrophages from cigarette smokers. Am. Rev. Respir. Dis. 118:979-986.
110. Costabel, U., and J. Guyman. 1992. Effect of smoking on bronchoalveolar lavage constituents. Eur. Respir. J. 5:776-779.
111. Swan, G. E., T. J. Roby, J. E. Hodgkin, C. Mittman, J. A. Peters, and N. Jacobo. 1994. Relationship of cytomorphology to spirometric findings in cigarette smokers. Acta Cytologica 38:547-553.
112. Koyama, S., S. I. Rennard, D. Daughton, S. Shoji, and R. A. Robbins. 1991. Bronchoalveolar lavage fluid obtained from smokers exhibits increased monocyte chemokinetic activity. J. Appl. Physiol. 70:1208-1214.
113. 4 dependent mechanism. Free Radic. Biol. Med. 22:947-954.
114. Hoogsteden, H. C., P. T. W. Van Hal, J. M. Wijkhuijs, W. Hop, A. P. K. Verkaik, and C. Hilvering. 1991. Expression of the CD11/CD18 cell surface adhesion glycoprotein family on alveolar macrophages in smokers and nonsmokers. Chest 100:1567-1571.
115. Kosmas, E. N., T. Roussou, K. Ikonomou, V. Vassailareas, S. Michaellides, V. Polychronopoulos, and C. N. Baxevania. 1996. Different patterns of intercellular adhesion molecule-1 (ICAM-1) and L-selectin expression on peripheral blood mononuclear cells in patients with chronic bronchitis and emphysema (abstract). Am. J. Respir. Crit. Care Med. 153:624A.
116. Senior, R. M., G. L. Griffin, and R. P. Mecham. 1980. Chemotactic activity of elastin-derived peptides. J. Clin. Invest. 66:859-862.
117. Zijlstra, F. J., J. E. Vincent, W. M. Mol, H. C. Hoogsteden, P. W. Van Hal, and R. C. Jongejan. 1992. Eicosanoid levels in bronchoalveolar lavage fluid of young female smokers and non-smokers. Eur. J. Clin. Invest. 22:301-306.
118. Hoidal, J. R., R. B. Fox, P. A. LeMarbe, R. Perri, and J. E. Repine. 1981. Altered oxidative metabolic responses in vitro of alveolar macrophages from asymptomatic cigarette smokers. Am. Rev. Respir. Dis. 123:85-89.
119. 2 release by alveolar macrophages and peripheral blood monocytes from smokers and nonsmokers. Am. Rev. Respir. Dis. 136:310-315.
120. Schaberg, T., H. Haller, M. Rau, D. Kaiser, M. Fassbender, and H. Lode. 1992. Superoxide anion release induced by platelet-activating factor is increased in human alveolar macrophages from smokers. Eur. Respir. J. 5:3877-3393.
121. Schaberg, T., U. Klein, M. Rau, J. Eller, and H. Lode. 1995. Subpopulation of alveolar macrophages in smokers and nonsmokers: relation to the expression of CD11/CD18 molecules and superoxide anion production. Am. J. Respir. Crit. Care Med. 151:1551-1558.
122. Greening, A. P., and D. B. Lowrie. 1983. Extracellular release of hydrogen peroxide by human alveolar macrophages: the relationship to cigarette smoking and lower respiratory tract infections. Clin. Sci. 65:661-664.
123. Drath, D. B., M. L. Karnovsky, and G. L. Huber. 1970. The effects of experimental exposure to tobacco smoke on the oxidative metabolism of alveolar macrophages. Journal of the Reticuloendothelial Society 25:597-604.
124. Lacoste, J. Y., J. Bousquet, P. Chanez, T. Van Vyve, J. Simony-Lafontaine, N. Laqueu, P. Vic, I. Enander, P. Godard, and F. B. Michel. 1993. Eosinophilic and neutrophilic inflammation in asthma, chronic bronchitis and chronic obstructive pulmonary disease. J. Allergy Clin. Immunol. 92:537-548.
125. Lebowitz, M. D., and D. S. Postma. 1995. Adverse effects of eosinophilic and smoking on the natural history of newly diagnosed chronic bronchitis. Chest 108:55-61.
126. Ruse, G. T., S. Ahlstedt, S. Larsson, I. Enander, I. Jones, P. Larsson, and B. Andersson. 1995. Bronchial inflammation in chronic bronchitis assessed by measurement of cell products in bronchial lavage fluid. Thorax 50:360-365.
127. Sedgwick, J. B., R. F. Vrtis, M. F. Gourley, and W. W. Busse. 1988. Stimulus-dependent differences in superoxide anion generation by normal human eosinophils and neutrophils. J. Allergy Clin. Immunol. 81:876-883.
128. Mabuchi, K., T. Sugiura, A. Ojima-Uchiyama, Y. Masuzawa, and K. Wako. 1992. Differential effects of platelet-activating factor on superoxide anion production in human eosinophils and neutrophils. Biochemistry International 26:1105-1113.
129. Hoidal, J. R., G. D. Beall, and J. E. Repine. 1979. Production of hydroxyl radical by human alveolar macrophages. Infect. Immunol. 26:1088-1092.
130. Zoratti, E. M., J. B. Sedgwick, R. F. Vrtis, and W. W. Busse. 1991. The effect of platelet-activating factor on the generation of superoxide anion in human eosinophils and neutrophils. J. Allergy Clin. Immunol. 88:749-758.
131. Toth, K. M., L. L. Burton, E. M. Berger, C. J. Beehler, T. C. Rodell, J. C. Cheronis, M. M. Halek, C. W. White, and J. E. Repine. 1987. Cigarette smoke exposure increases erythrocyte (RBC) and lung antioxidant levels and lung xanthine oxidase (XO) activities (abstract). Clin. Res. 35:172A.
132. Phan, S. H., D. E. Gannon, P. A. Ward, and S. Karmiol. 1992. Mechanisms of neutrophil-induced xanthine dehydrogenase to xanthine oxidase conversion in endothelial cells: evidence of a role for elastase. Am. J. Respir. Cell Mol. Biol. 6:270-278.
133. Petrone, W. F., D. K. English, K. Wong, and J. M. McCord. 1980. Free radicals and inflammation: superoxide dependent activation of a neutrophil chemotactic factor in plasma. Proc. Natl. Acad. Sci. U.S.A. 77:1159-1163.
134. Pinamonti, S., M. Muzzuli, M. C. Chicca, A. Papi, F. Ravenna, L. M. Fabri, and A. Ciaccia. 1996. Xanthine oxidase activity in bronchoalveolar lavage fluid from patients with chronic obstructive lung disease. Free Radic. Biol. Med. 21:147-155.
135. DeKhuijzen, P. N. R., K. K. H. Aben, I. Dekker, L. P. H. J. Aarts, P. L. M. L. Weidlers, C. L. A. van Herwaarden, and A. Bast. 1996. Increased exhalation of hydrogen peroxide in patients with stable and unstable chronic obstructive pulmonary disease. Am. J. Respir. Crit. Care Med. 154:813-816.
136. Rahman, I., and W. MacNee. 1996. Role oxidants/antioxidants in smoking induced lung diseases. Free Radic. Biol. Med. 21:669-681.
137. Tager, T., and F. E. Speizer. 1975. Role of infection of chronic bronchitis. N. Engl. J. Med. 292:563.
138. Gump, D. W., C. A. Phillips, B. R. Forsyth, K. McIntosh, K. R. Lamborn, and W. H. Stouch. 1976. Role of infection in chronic bronchitis. Am. Rev. Respir. Dis. 113:465-474.
139. Haas, H., J. F. Morris, S. Samson, J. P. Kilbourn and P. J. Kim. 1977. Bacterial flora of the respiratory tract in chronic bronchitis: comparison of transtracheal, fiberbronchoscopic, and oropharyngeal sampling methods. Am. Rev. Respir. Dis. 116:41-47.
140. Chodosh, S. 1987. Acute bacterial exacerbations in bronchitis and asthma. Am. J. Med. 82:154-163.
141. Riise, G. C., S. Larsson, and B. A. Andersson. 1994. Bacterial adhesion to oropharyngeal and bronchial epithelial cells in smokers with chronic bronchitis, smaller with COPD and healthy nonsmokers. Eur. Respir. J. 7:1759-1764.
142. Irwin, R. S., A. D. Erickson, M. R. Pratter, W. M. Currso, F. L. Garrity, J. R. Myers, and J. T. Kaemmerlen. 1982. Prediction of tracheobronchial colonization in current cigarette smokers with chronic obstructive bronchitis. J. Invest. Dis. 145:234-241.
143. Beachey, E. H., G. S. Giampapa, and S. N. Abraham. 1988. Bacterial adherence: adhesion receptor-mediated attachment of pathogenic bacteria to mucosal surfaces. Am. Rev. Respir. Dis. 138:S45-S48.
144. Plotkowski, M. C., O. Bajolet-Laudinat, and E. Puchelle. 1993. Cellular and molecular mechanisms of bacterial adhesion to respiratory mucosa. Eur. Respir. J. 6:903-916.
145. Raman, A. S., A. J. Swimhume, and A. J. Fedullo. 1983. Pneumococcal adherence to the buccal epithelial cells of cigarette smokers. Chest 83:23-27.
146. Feinstein, V., and D. Musher. 1979. Bacterial adherence to pharyngeal cells in smokers, nonsmokers, and chronic bronchitis. Infect. Immunol. 26:178-182.
147. Taylor, J. C., R. Madison, and D. Kosinska. 1986. Is antioxidant deficiency related to chronic obstructive pulmonary disease? Am. Rev. Respir. Dis. 134:285-289.
148. Duthie, G. G., J. R. Arthur, and W. P. James. 1991. Effects of smoking and vitamin E on blood antioxidant status. Am. J. Clin. Nutr. 53:1061-1063.
149. Jendrychko, A., G. Szoyrka, J. Gruszczynski, and M. Kozowicz. 1993. Cigarette smoke exposure of school children: effect of passive smoking and vitamin E supplementation on blood antioxidant status. Neoplasia 40:199-203.
150. Murata, A., L. Shiraski, K. Fukazaki, T. Kittara, and Y. Arada. 1989. Lower levels of vitamin C in plasma and urine of Japanese male smokers. Int. J. Vitam. Nutr. Res. 59:184-189.
151. Duthie, G. G., J. R. Arthur, J. A. Beattie, K. M. Brown, P. C. Morrice, J. D. Robertson, C. T. Shortt, K. A. Walker, and W. P. James. 1993. Cigarette smoking, antioxidants, lipid peroxidation, and coronary heart disease. Ann. N. Y. Acad. Sci. 686:120-129.
152. Anderson, R. 1991. Assessment of the roles of vitamin C, vitamin E, and β-carotene in the modulation of oxidant stress mediated by cigarette smoke-activated phagocytes. Am. J. Clin. Nutr. 53:358-361.
153. Anderson, R., A. J. Theron, and G. J. Ras. 1988. Ascorbic acid neutralizes reactive oxidants released by hyperactive phagocytes from cigarette smokers. Lung 166:149-159.
154. Chow, C. K., R. R. Thacker, C. Changchit, R. B. Bridges, S. R. Rehm, J. Humble, and J. Turbek. 1986. Lower levels of vitamin C and carotenes in plasma of cigarette smokers. J. Am. Coll. Nutr. 5:305-312.
155. Van Poppel, G., S. Spanhaak, and T. Ockhuzen. 1993. Effect of beta-carotene on immunological indexes in healthy male smokers. Am. J. Clin. Nutr. 57:402-407.
156. Basu, J., M. S. Mikhail, P. H. Paysaudean, P. R. Palan, and S. L. Romney. 1990. Smoking and the antioxidant ascorbic acid: plasma, leukocyte, and cervicovaginal cell concentrations in normal healthy women. Am. J. Obstet. Gynecol. 163:1948-1952.
157. Schectman, G., J. C. Byrd, and H. W. Gruehow. 1989. The influence of smoking on vitamin C status in adults. Am. J. Public Health 79:158-162.
158. Schectman, G. 1993. Estimating ascorbic acid requirements for cigarette smokers. Ann. N.Y. Acad. Sci. 686:335-345.
159. VanRensburg, C. E. J., A. Theron, G. A. Richards, C. A. van der Merwe, and R. Anderson. 1989. Investigation of the relationships between plasma levels of ascorbate, vitamin E and β-carotene and the frequency of sister-chromatid exchanges and release of reactive oxidants by blood leukocytes from cigarette smokers. Mutat. Res. 215:167-172.
160. Pelletier, O. 1986. Vitamin C status of cigarette smokers and non-smokers. J. Am. Coll. Nutr. 5:305-312.
161. Antwerpen, L. V., A. J. Theron, M. S. Myer, G. A. Richards, L. Wolmarans, and U. Booysen. 1993. Cigarette smoke-mediated oxidant stress, phagocytes, vitamin C, vitamin E and tissue injury. Ann. N.Y. Acad. Sci. 686:53-65.
162. Theron, A. J., G. A. Richard, A. J. Rensburg, C. A. Vander Merwe, and R. Anderson. 1990. Investigation of the role of phagocytes and antioxidant nutrients in oxidant stress mediated by cigarette smoke. Int. J. Vitam. Nutr. Res. 60:261-266.
163. Kondo, T., S. Tsgami, A. Yohioka, M. Nishumura, and Y. Kawakami. 1994. Current smoking of elderly men reduces antioxidants in alveolar macrophages. Am. J. Respir. Crit. Care Med. 149:178-182.
164. Pacht, E. R., H. Kaseki, J. R. Mohammed, D. G. Cornwell, and W. B. Davis. 1986. Deficiency of vitamin E in the alveolar fluid of cigarette smokers: influence on alveolar macrophage cytotoxicity. J. Clin. Invest. 77:789-796.
165. Comstock, G. W., M. S. Menkes, S. E. Schober, J. P. Vuilleumier, and K. F. Helsing. 1988. Serum levels of retinal β-carotene and alpha tocopherol in older adults. Am. J. Epidemiol. 127:114-123.
166. Mezzetti, A., D. Lapenna, S. D. Pierdomenico, A. M. Calafiore, F. Costantini, G. Riario-Sforza, T. Imbastaro, M. Neri, and F. Cuccurullo. 1995. Vitamins E, C and lipid peroxidation in plasma and arterial tissue of smokers and non-smokers. Atherosclerosis 112:91-99.
167. Bui, M. H., A. Saury, F. Collet, and P. Leuenberger. 1992. Dietary vitamin C intake and concentrations in the body fluids and cells of male smokers and non-smokers. J. Nutr. 122:312-316.
168. McGowan, S. E., C. M. Parenti, J. R. Hoidal, and D. E. Niewoehner. 1984. Differences in ascorbic acid content and accumulation by alveolar macrophages from cigarette smokers and non-smokers. J. Lab. Clin. Med. 104:127-134.
169. Lehr, H. A., B. Frei, and K. E. Arfors. 1994. Vitamin C prevents cigarette smoke-induced leukocyte aggregation and adhesion to endothelium in vivo. Proc. Natl. Acad. Sci. U.S.A. 91:7688-7692.
170. Chow, C. K., L. H. Chen, R. R. Thacker, and R. B. Griffith. 1984. Dietary vitamin E and pulmonary biochemical responses of rats to cigarette smoke. Exp. Mol. Pathol. 38:368-379.
171. Schwartz, J., and S. T. Weiss. 1994. Relationship between dietary vitamin C intake and pulmonary function in the First National Health and Nutrition Examination Survey (NHANES 1). Am. J. Clin. Nutr. 59:1110-1114.
172. α-Tocopherol, β-Carotene Prevention Study Group. 1994. The effect of vitamin E and beta carotene on the incidence of lung cancer and other cancers in male smokers. N. Engl. J. Med. 330:1029-1035.
173. Rowe, P. M. 1996. Beta-carotene takes a collective beating. Lancet 347:249.
174. Kathawalla, S. A., S. Comhair, and S. C. Erzurum. 1996. Correlation of secretory glutathione peroxidase and glutathione in airways of smoking individuals (abstract). Am. J. Respir. Crit. Care Med. 153:A812.
175. Linden, M., L. Hakansson, K. Ohlsson, K. Sjodin, A. Tegner, A. Tunek, and P. Venge. 1989. Glutathione in bronchoalveolar lavage fluid from smokers is related to humoral markers of inflammatory cell activity. Inflammation 13:651-658.
176. Li, X. Y., K. Donaldson, I. Rahman, and W. MacNee. 1994. An investigation of the role of glutathione in increased epithelial permeability induced by cigarette smoke in vivo and in vitro. Am. J. Respir. Crit. Care Med. 149:1518-1525.
177. Lannen, S., K. Donaldson, D. Brown, and W. MacNee. 1994. Effect of cigarette smoke and its condensates on alveolar epithelial cell injury in vitro. Am. J. Physiol. 266:91-100.
178. Jones, J. G., P. Lawler, J. C. W. Crawley, B. D. Minry, G. Hulands, and N. Veall. 1990. Increased alveolar epithelial permeability in cigarette smokers. Lancet 1:66-68.
179. Morrison, D., S. Lannan, A. Langridge, I. Rahman, and W. MacNee. 1996. Effect of acute cigarette smoking on epithelial permeability, inflammation and oxidant status in the airspaces of chronic smokers. Thorax 49:1077.
180. Toth, K. M., E. M. Berger, C. J. Beehler, and J. E. Repine. 1986. Erythrocytes from cigarette smokers contain more glutathione and catalase and protect endothelial cells from hydrogen peroxide better than erythrocytes from nonsmokers. Am. Rev. Respir. Dis. 134:281-284.
181. Mangione, S., F. Kueppers, C. Puglia, and L. W. Greenspon. 1991. Erythrocytes prevent inactivation of alpha-1-antitrypsin by cigarette smoke. Eur. Respir. J. 4:26-30.
182. Mukherjee, S., L. Woods, Z. Weston, A. B. Williams, and S. K. Das. 1993. The effect of mainstream and sidestream cigarette smoke exposure on oxygen defense mechanisms of guinea pig erythrocytes. J. Biochem. Toxicol. 8:119-125.
183. Sohn, H. O., H. B. Lim, Y. G. Lee, D. W. Lee, and Y. T. Kim. 1993. Effect of subchronic administration of antioxidants against cigarette smoke exposure in rats. Arch. Toxicol. 67:667-673.
184. Rahman, I., M. Lawson, D. J. Harrison, and W. MacNee. 1994. γ-Glutamyl cysteine synthetase induction by cigarette smoke exposure in alveolar epithelial cells. Respir. Med. 88:809.
185. McCusker, K., and J. Hoidal. 1990. Selective increase of antioxidant enzyme activity in the alveolar macrophage from cigarette smokers and smoke-exposed hamsters. Am. Rev. Respir. Dis. 141:678-682.
186. Repine, J. E. 1994. Interleukin-1-mediated acute lung injury and tolerance to oxidative injury. Environ. Health Perspect. 102:75-78.
187. York, G. K., T. H. Pierce, L. W. Schwartz, and C. E. Cross. 1976. Stimulation by cigarette smoke of glutathione peroxidase system enzyme activities in rat lung. Arch. Environ. Health 31:286-289.
188. Rushmore, T. H., M. R. Morton, and C. B. Pickett. 1991. The antioxidant response element: activation by oxidative stress and identification of the DNA consensus sequence required for functional activity. J. Biol. Chem. 266:11632-11639.
189. Repine, J. E. 1991. Oxidant-antioxidant balance: some observations from studies in isolated rat hearts subjected to ischemia-reperfusion. Am. J. Med. 91:45-53.
190. Costagliola, C., M. Rinaldi, A. Giacola, S. Ropsaka, L. Cotticelli, and E. Rinaldi. 1989. Red cell glutathione as a marker of tobacco smoke induced optic neuropathy. Exp. Eye Res. 48:583-586.
191. Chow, C. K. 1993. Cigarette smoking oxidative damage in the lung. Ann. N.Y. Acad. Sci. 686:289-298.
192. Sznajder, J. I., A. Fraiman, J. B. Hall, W. Sanders, G. Schmidt, G. Crawford, A. Nahurn, P. Factor, and L. D. Wood. 1989. Increased hydrogen peroxide in the expired breath of patients with acute hypoxemic respiratory failure. Chest 96:606-612.
193. Halliwell, B., and S. Chirico. 1993. Lipid peroxidation: its mechanism, measurement and significance. Am. J. Clin. Nutr. 57:715-725.
194. Hageman, J. J., A. Bast, and N. P. E. Vermeulen. 1992. Monitoring of oxidative free radical damage in vivo: analytical aspects. Chem. Biol. Interact. 82:243-293.
195. Thomas, D. W., F. J. G. M. van Kuijk, E. A. Dratz, and R. J. Stephens. 1991. Quantitative determination of 6-hydroxy fatty acids as an indicator of in vivo lipid peroxidation: gas chromatography-mass spectrometry methods. Anal. Biochem. 198:104-111.
196. Miyazawa, T. 1989. Determination of phospholipid hydroperoxides in human blood plasma by chemiluminescence HPLC assay. Free Radic. Biol. Med. 7:208-217.
197. Van Gossum, A., and J. Decuyper. 1989. Breath alkane as an index of lipid peroxidation. Eur. Respir. J. 2:787-791.
198. Frei, B., T. M. Forte, B. N. Ames, and C. E. Cross. 1991. Gas-phase oxidants of cigarette smoke induce lipid peroxidation and changes in lipoprotein properties in human blood. Biochem. J. 277:133-138.
199. Nadiger, H. A., C. A. Mathew, and B. Sadasivudu. 1987. Serum malondialdehyde (TBA reactive substance) levels in cigarette smokers. Atherosclerosis 64:71-73.
200. Kalra, J., A. K. Chaudhary, and K. Prasad. 1991. Increased production of oxygen free radicals in cigarette smokers. Int. J. Exp. Pathol. 72:1-7.
201. Cross, C. E., C. A. O'Neill, A. Z. Reznick, M. L. Hu, L. Marcocci, L. Packer, and B. Frei. 1993. Cigarette smoke oxidation of human plasma constituents. Ann. N.Y. Acad. Sci. 686:72-89.
202. Pre, J., A. LeFloch, R. Vassg, and C. Lenoble. 1989. Increased plasma levels of fluorescent lipid peroxidation products in cigarette smokers. Med. Sci. Res. 17:1029-1030.
203. Bridges, A. B., N. A. Scott, G. J. Parry, and J. J. F. Belch. 1993. Age, sex, cigarette smoking and indices of free radical activity in healthy humans. Eur. J. Med. 2:205-208.
204. Barnes, P. J. 1990. Reactive oxygen species and airway inflammation. Free Radic. Biol. Med. 9:235-243.
205. Petruzzelli, S., E. Hietanen, H. Bartsch, A. M. Camus, A. Mussi, C. A. Angeletti, R. Saracci, and C. Giuntini. 1990. Pulmonary lipid peroxidation in cigarette smokers and lung cancer patients. Chest 98:930-935.
206. Lapenna, D., A. Mezzetti, S. D. Giola, S. Pierdomenico, F. Danielee, and F. Cuccurullo. 1995. Plasma copper and lipid peroxidation in cigarette smokers. Free Radic. Biol. Med. 19:849-852.
207. Hobson, J., J. Wright, and A. Churg. 1991. Histochemical evidence for generation of active oxygen species on the apical surface of cigarette smoke-exposed tracheal explants. Am. J. Pathol. 139:573-580.
208. Lentz, P. E., and N. R. DiLuzio. 1974. Peroxidation of lipids in alveolar macrophages: production by aqueous extracts of cigarette smoke. Arch. Environ. Health 28:279-282.
209. Hoshino, E., R., Shariff, A. Van Gossum, J. P. Allard, C. Pichard, R. Kurian, and K. N. Jeejeebhoy. 1990. Vitamin E supresses increased lipid peroxidation in cigarette smokers. Journal of Parenteral and Enteral Nutrition 14:300-305.
210. Habib, M. P., B. K. Q. Do, N. C. Clements, and H. S. Garewal. 1996. Fall in exhaled ethane (EE) in smokers after antioxidants associated with preserved lung function (abstract). Am. J. Respir. Crit. Care Med. 153:A740.
211. Gutteridge, J. M. C., and B. Halliwell. 1990. The measurement and mechanisms of lipid peroxidation in biological systems. Trends Biochem. Sci. 15:129-135.
212. 2-isoprostanes) in smokers: smoking as a cause of oxidative damage. N. Engl. J. Med. 332:1198-1203.
213. Miller, E. 1978. Some current perspectives on chemical carcinogenesis in humans and experimental animals: presidential address. Cancer Res. 38:1479-1496.
214. Cuzick, J., M. N. Routledge, D. Jenkins, and X. C. Gamer. 1990. DNA adducts in different tissues of smokers and non-smokers. Int. J. Cancer 45:673-678.
215. Nakayama, T., M. Kaneko, M. Kodama, and C. Nagate. 1985. Cigarette smoke induces DNA single-strand breaks in human cells. Nature 314:462-464.
216. Spencer, J. P. E., A. Jenner, K. Chimel, O. I. Aruoma, C. E. Cross, R. Wu, and B. Halliwell. 1995. DNA damage in human respiratory tract epithelial cells: damage by gas phase cigarette smoke apparently involves attack by reactive nitrogen species in addition to oxygen radicals. FEBS Lett. 375:179-182.
217. Jackson, J. H., I. U. Schraufstatter, P. A. Hyslop, K. Vosbeck, R. Sauerheber, S. A. Weitzman, and C. G. Cochrane. 1987. Role of oxidants in DNA damage: hydroxyl radical mediates the synergistic DNA damaging effects of asbestos and cigarette smoke. J. Clin. Invest. 80:1090-1095.
218. Kiyosawa, H., M. Suko, H. Okudaira, K. Murata, T. Miyamoto, M.-H. Chung, H. Kasai, and S. Nishimura. 1990. Cigarette smoking induces formation of 8-hydroxydeoxyguanosine, one of the oxidative DNA damages in human peripheral leukocytes. Free Radic. Res. Commun. 11:23-27.
219. Leanderson, P., and C. Tagesson. 1992. Cigarette smoke-induced DNA damage in cultured human lung cells: role of hydroxyl radicals and endonuclease activation. Chem. Biol. Interact. 81:197-208.
220. Schwalb, G., and R. Anderson. 1989. Increased frequency of oxidant-mediated DNA strand breaks in mononuclear leukocytes exposed to activated neutrophils from cigarette smokers. Mutation Res. 228:95-99.
221. Hecht, S. S., S. C. Carmella, P. G. Foiles, and S. E. Murphy. 1994. Biomarkers of human uptake and metabolic activation of tobacco-specific nitrosamines. Cancer Res. 54:1912-1917.
222. Van Schooten, F. J., M. J. X. Hillebrand, F. E. Van Leeuwen, J. T. Lutgerink, N. Van Zandwijk, H. M. Jansen, and E. Kriek. 1990. Polycyclic aromatic hydrocarbon-DNA adducts in lung tissue from lung cancer patients. Carcinogenesis 11:1677-1681.
223. 22P-postlabeling assay. Carcinogenesis 14:545-550.
224. Petruzzelli, S., L. M. Tavanti, A. Celi, and C. Giuntini. 1996. Detection of N7-methyldeoxygunosine in human pulmonary alveolar cells. Am. J. Respir. Cell Mol. Biol. 15:216-223.
225. Brennan, J. A., J. O. Boyle, W. M. Koch, S. N. Goodman, R. H. Hruban, Y. J. Eby, M. J. Couch, A. A. Forastiere, and D. Sidransky. 1995. Association between cigarette smoking and mutation of the P53 gene in squamous-cell carcinoma of the head and neck. N. Engl. J. Med. 332:712-717.
226. Slebos, R. J. C., R. H. Hruban, O. Dalesio, W. J. Mooi, G. J. A. Offerhaus, and S. Rodenhuis. 1991. Relationship between K-ras oncogene activation and smoking in adenocarcinoma of the human lung. J. Natl. Cancer Inst. 83:1024-1027.
227. Stadtman, E. R. 1990. Metal ion-catalyzed oxidation of proteins: biochemical mechanism and biological consequences. Free Radic. Biol. Med. 9:315-325.
228. Reznick, A. Z., C. E. Cross, M. L. Hu, Y. J. Suzuki, S. Khwaja, A. Safadi, P. A. Motchnik, L. Packer, and B. Halliwell. 1992. Modification of plasma proteins by cigarette smoke as measured by protein carbonyl formation. Biochem. J. 286:607-611.
229. O'Neill, C. A., B. Halliwell, A. van der Vliet, P. A. Davis, L. Packer, H. Tritschler, W. J. Strohman, T. Rieland, C. E. Cross, and A. Z. Reznick. 1994. Aldehyde-induced protein modifications in human plasma: protection by glutathione and dihydrolipoic acid. J. Lab. Clin. Med. 124:359-370.
230. Lenz, A. G., U. Costabel, and K. L. Maier. 1996. Oxidized BAL fluid proteins in patients with interstitial lung diseases. Eur. Respir. J. 9:307-312.
231. Piquette, C. A., and S. I. Rennard. 1996. Chronic bronchitis: focus on maintaining pulmonary function. Intern. Med. 82-91.
232. Rubin, B. K., and M. King. 1993. The physiologic effects of smoking in COPD. J. Respir. Dis. 14:19.
233. Ferguson, G. T., and R. M. Cherniack. 1993. Management of chronic obstructive pulmonary disease. N. Engl. J. Med. 328:1017-1022.
234. Schilero, G. J., P. L. Almenoff, and M. Lesser. 1995. Changing therapies for COPD. Intern. Med. 17-32.
235. Anthonisen, N. R., J. E. Connett, J. P. Kiley, M. D. Altose, W. C. Bailey, A. S. Buist, W. A. J. Conway, P. L. Enright, R. E. Kanner, P. O'Hara, et al. 1994. Effects of smoking intervention and the use of an inhaled anticholinergic bronchodilator on the rate of decline of FEV1: The Lung Health Study. J.A.M.A. 272:1497-1505.
236. Rennard, S. I., D. Daughton, J. Fujita, M. Oehlerking, J. R. Dobson, M. G. Stahl, R. A. Robbins, and A. B. Thompson. 1990. Short-term smoking reduction is associated with reduction in measures of lower respiratory tract inflammation in heavy smokers. Eur. Respir. J. 3:752-759.
237. Skold, C. M., J. Hed, and A. Eklund. 1992. Smoking cessation rapidly reduces cell recovery in bronchoalveolar lavage fluid, while alveolar macrophage fluorescence remains high. Chest 101:989-995.
238. COMBIVENT Inhalation Aerosol Study Group. 1994. In Chronic obstructive pulmonary disease, a combination of ipratropium and albuterol is more effective than either agent alone. Chest 105:1411-1419.
239. Easton, P. A., C. Jadue, S. Dhingra, and N. R. Anthonisen. 1986. A comparison of the bronchodilating effects of a beta-2 adrenergic agent (albuterol) and an anticholinergic agent (ipratropium bromide), given by aerosol alone or in sequence. N. Engl. J. Med. 315:735-739.
240. Karpel, J. P., J. Pesin, E. Greenberg, and E. Gentry. 1990. A comparison of the effects of ipratropium bromide and metaproterenol sulfate in acute exacerbations of COPD. Chest 98:835-839.
241. Llewellyn-Jones, C. G., and R. A. Stockley. 1994. The effects of B2-agonists and methylxanthines on neutrophil function in vitro. Eur. Respir. J. 73:1460-1466.
242. Llewellyn-Jones, C. G., S. L. Hill, and R. A. Stockley. 1994. Effect of fluticasone propionate on neutrophil chemotaxis, superoxide generation, and extracellular proteolytic activity in vitro. Thorax 49:207-212.
243. Nielson, C. P., J. J. Crowley, B. J. Cusack, and R. E. Vestal. 1986. Therapeutic concentrations of theophylline and enprofylline potentiate catecholamine effects and inhibit leukocyte activation. J. Allergy Clin. Immunol. 78:660-667.
244. Nielson, C. P., J. J. Crowley, M. E. Morgan, and R. E. Vestal. 1988. Polymorphonuclear leukocyte inhibition by therapeutic concentrations of theophylline is mediated by cyclic-3′,5′-adenosine monophosphate. Am. Rev. Respir. Dis. 137:25-30.
245. Nielson, C. P., R. E. Vestal, R. J. Sturm, and R. Heaslip. 1990. Effects of selective phosphodiesterase inhibitors on the polymorphonuclear leukocyte respiratory burst. J. Allergy Clin. Immunol. 86:801-808.
246. Schrier, D. J., and K. M. Imre. 1986. The effects of adenosine agonists on human neutrophil function. J. Immunol. 137:3284-3289.
247. Kaneko, M., K. Suzuki, H. Furui, K. Takagi, and T. Satake. 1990. Comparison of theophylline and enprofylline effects on human neutrophil superoxide production. Clin. Exp. Pharmacol. Physiol. 17:849-859.
248. Yukawa, T., C. Kroegel, P. Chanez, G. Dent, D. Ukena, K. F. Chung, and P. J. Barnes. 1989. Effect of theophylline and adenosine on eosinophil function. Am. Rev. Respir. Dis. 140:327-333.
249. Hudson, L. D., and C. M. Monti. 1990. Rationale and use of corticosteroids in chronic obstructive pulmonary disease. Med. Clin. North Am. 74:661-690.
250. Postma, D. S., and T. E. J. Renkema. 1995. Corticosteroid treatment. In P. Calverley and N. Pride, editors. Chronic Obstructive Pulmonary Disease. Chapman & Hall, London. 447-459.
251. Callahan, C. M., R. S. Dittus, and B. P. Katz. 1991. Oral corticosteroid therapy for patients with stable chronic obstructive pulmonary disease: a metaanalysis. Ann. Intern. Med. 114:216-223.
252. Engel, T., J. H. Heinig, O. Madsen, M. Hansen, and E. R. Wecke. 1989. A trial of inhaled budesonide on airway responsiveness in smokers with chronic bronchitis. Eur. Respir. J. 2:935-939.
253. Auffarth, B., D. S. Postma, J. G. R. de Monchy, T. W. van der Mark, M. Boorsma, and G. H. Koëter. 1991. Effects of inhaled budesonide on spirometric values, reversibility, airway responsiveness, and cough threshold in smokers with chronic obstructive lung disease. Thorax 46:372-377.
254. Watson, A., T. K. Lim, H. Joyce, and N. B. Pride. 1992. Failure of inhaled corticosteroids to modify bronchoconstrictor or bronchodilator responsiveness in middle-aged smokers with mild airflow obstruction. Chest 101:350-355.
255. Dompeling, E., C. P. van Schayck, P. M. van Grunsven, C. L. A. van Herwaarden, R. Akkermans, J. Molema, H. T. M. Folgering, and C. van Weel. 1993. Slowing the deterioration of asthma and chronic obstructive pulmonary disease observed during bronchodilator therapy by adding inhaled corticosteroids: a four-year prospective study. Ann. Intern. Med. 118:770-778.
256. Fukushima, K., M. Ando, K. Ito, M. Suga, and S. Araki. 1990. Stimulus- and cumulative dose-dependent inhibition of O2-production by polymorphonuclear leukocytes of patients receiving corticosteroids. J. Clin. Lab. Immunol. 33:117-123.
257. 2 generation by neutrophils in emphysema. Eur. Respir. J. 6:90-95.
258. Lomas, D. A., M. Ip, A. Chamba, and R. A. Stockley. 1991. The effect of in vitro and in vivo dexamethasone on human neutrophil function. Agents Actions 33:279-285.
259. DeBacker, W. A., J. Pecivora, E. J. van Overweld, and P. A. Vermeire. 1996. The effects of treatment with inhaled corticosteroids on inflammation in stable chronic obstructive pulmonary disease (abstract). Am. J. Respir. Crit. Care Med. 153:A822.
260. Keatings, V. M., A. Jatakanon, and P. F. Barnes. 1996. Oral corticosteroids do not reduce eosinophil numbers or concentrations of eosinophilic cationic protein in chronic obstructive pulmonary disease (abstract). Am. J. Respir. Crit. Care Med. 153:A823.
261. Rubin, R. P., R. H. Thompson, and M. S. Naps. 1990. Differential inhibition by nedocromil sodium of superoxide generation elicited by platelet activating factor in human neutrophils. Agents Actions 31:237-242.
262. Nowak, D., A. Antczak, M. Krol, P. Bialasiewicz, and T. Pietras. 1994. Antioxidant properties of ambroxol. Free Radic. Biol. Med. 16:517-522.
263. Olivieri, D., G. Zavattini, G. Tomasini, S. Daniotti, G. Bonsignore, G. Ferrara, N. Carnimeo, R. Chianese, E. Catena, S. Marcatili, et al. 1987. Ambroxol for the prevention of chronic bronchitis exacerbations: long-term multicenter trial. Protective effect of ambroxol against winter semester exacerbations: a double-blind study versus placebo. Respiration 51:42-51.
264. Roger, N., J. A. Barbera, R. Farre, A. Cobos, J. Roca, and R. Rodriquez. 1996. Effect of nitric oxide inhalation on respiratory system resistance in chronic obstructive pulmonary disease. Eur. Respir. J. 9:190-195.
265. Menzel, D. B. 1992. Antioxidant vitamins and prevention of lung disease. Ann. N.Y. Acad. Sci. 669:141-145.
266. Sarnstrand, B. 1992. Is n-acetylcysteine a free radical scavenger in vivo? The effect of n-acetylcysteine in oxygen induced lung injury. Eur. Respir. Rev. 2:11-15.
267. Aruoma, O. I., B. Halliwell, B. M. Hoey, and J. Butler. 1989. The anti-oxidant action of N-acetylcysteine: its reaction with hydrogen peroxide, hydroxyl radical, superoxide, and hypochlorous acid. Free Radic. Biol. Med. 6:593-597.
268. Moldeus, P., I. A. Cotgreave, and M. Berggren. 1986. Lung protection by a thiol-containing antioxidant: N-acetylcysteine. Respiration 50:31-42.
269. Cotgreave, I. A., and P. Moldeus. 1987. Lung protection by thiol-containing antioxidants. Bull. Eur. Physiopathol. Respir. 23:275-277.
270. Schreck, R., K. A. J. Albermann, and P. A. Baeuerle. 1992. Nuclear factor kB: an oxidative stress-responsive transcription factor of eukaryotic cells (a review). Free Radic. Res. Commun. 17:221-237.
271. Bridges, A. B. 1985. Protective action of thiols on neutrophil function. Eur. J. Respir. Dis. 66:40-48.
272. Voisin, C., C. Aerts, and B. Wallaert. 1987. Prevention of in vitro oxidant-mediated alveolar macrophage injury by cellular glutathione and precursors. Bull. Eur. Physiopathol. Respir. 23:309-313.
273. Linden, M., E. Wieslander, A. Eklund, K. Larsson, and R. Brattsand. 1988. Effects of oral N-acetylcysteine on cell content and macrophage function in bronchoalveolar lavage from healthy smokers. Eur. Respir. J. 1:645-650.
274. Moldeus, P., M. Berggren, and R. Graffström. 1985. N-acetylcysteine protection against the toxicity of cigarette smoke and cigarette smoke condensates in various tissues and cells in vitro. Eur. J. Respir. Dis. 66(Suppl. 139):123-129.
275. Drost, E., S. Lannan, M. M. E. Bridgeman, D. Brown, C. Selby, K. Donaldson, and W. MacNee. 1991. Lack of effect of N-acetylcysteine on the release of oxygen radicals from neutrophils and alveolar macrophages. Eur. Respir. J. 4:723-729.
276. Jeffery, P. K., D. F. Rogers, and M. M. Ayers. 1985. Effect of oral acetylcysteine on tobacco smoke-induced secretory cell hyperplasia. Eur. J. Respir. Dis. 66:117-122.
277. Borregaard, N., H. S. Jensen, and O. W. Bjerrum. 1987. Prevention of tissue damage: inhibition of myeloperoxidase mediated inactivation of alpha-1-proteinase inhibitor by N-acetylcysteine, glutathione, and methionine. Agents Actions 22:255-260.
278. Anderson, L. W., J. Thirs, A. Kharazami, and I. Rygg. 1995. The role of N-acetylcysteine administration on the oxidative response of neutrophils during cardiopulmonary bypass. Perfusion 10:21-26.
279. Bridgeman, M. M. E., M. Marsden, W. MacNee, D. C. Flenley, and A. P. Ryle. 1991. Cysteine and glutathione concentrations in plasma and bronchoalveolar lavage fluid after treatment with N-acetylcysteine. Thorax 46:39-42.
280. Jankowska, R., E. Passowiez-Muszynska, W. Medrala, T. Banas, and A. Marcinkowska. 1993. The influence of N-acetylcysteine on granulocyte chemiluminescence in patients with chronic bronchitis. Pneumonol. Alergol. Pol. 61:586-591.
281. Multicenter Study Group. 1980. Long-term oral acetylcysteine in chronic bronchitis: a double-blind controlled study. Eur. J. Respir. Dis. 61:93-108.
282. Aylward, M., J. Maddock, and P. Dewland. 1980. Clinical evaluation of acetylcysteine in the treatment of patients with chronic obstructive bronchitis: a balanced double-blind trial with placebo control. Eur. J. Respir. Dis. 61:81-89.
283. Boman, G., U. Bäcker, S. Larsson, B. Melander, and L. Wählander. 1983. Oral acetylcysteine reduces exacerbation rate in chronic bronchitis: report of a trial organized by the Swedish Society for Pulmonary Diseases. Eur. J. Respir. Dis. 64:405-415.
284. Rasmussen, J. B., and C. Glennon. 1988. Reduction in days of illness after long-term treatment with N-acetylcysteine controlled-release tablets in patients with chronic bronchitis. Eur. Respir. J. 1:351-355.
285. McFarlane, J. T. 1985. Oral N-acetylcysteine and exacerbation rates in patients with chronic bronchitis and severe airways obstruction. Thorax 40:832-835.
286. British Thoracic Society Research Committee. 1985. Oral N-acetylcysteine and exacerbation rates in patients with chronic bronchitis and severe airways obstruction. Thorax 40:832-835.
287. Todisco, T., G. C. Palmieri, A. Pezza, and L. Carati. 1993. Protective effect of N-acetylcysteine on immune system of elderly patients in acute respiratory viral infections. Eur. Respir. J. 6:559.
288. Matsuse, T., S. Hayashi, K. Kuwano, H. Keunecke, W. A. Jefferies, and J. C. Hogg. 1992. Latent adenoviral infection in the pathogenesis of chronic airways obstruction. Am. Rev. Respir. Dis. 146:177-184.
289. Ruse, G. C., S. Larsson, P. Larsson, S. Jeansson, and B. A. Andersson. 1994. The intrabronchial microbial flora in chronic bronchitis patients: a target for N-acetylcysteine therapy? Eur. Respir. J. 7:94-101.
290. Lundbäck, B., M. Linström, S. Andersson, L. Nyström, L. Rosenhall, and N. Stjernberg. 1995. Possible effect of acetylcysteine on lung function. Eur. Respir. J. 5(Suppl. 15):895.
291. MacKenzie, T. D., C. E. Bartecchi, and R. W. Schrier. 1994. The human costs of tobacco abuse. N. Engl. J. Med. 330:975-980.
292. McCusker, K. 1992. Mechanisms of respiratory tissue injury from cigarette smoking. Am. J. Med. 93:18-21.
293. Burchfiel, C. M., E. B. Marcus, J. D. Curb, C. J. MacLean, W. M. Vollmer, L. M. Johnson, K.-O. Fong, B. L. Rodriguez, K. H. Masaki, and A. S. Buist. 1995. Effects of smoking and smoking cessation on longitudinal decline in pulmonary function. Am. J. Respir. Crit. Care Med. 151:1778-1785.
294. Nocturnal Oxygen Therapy Trial Group. 1980. Continuous or nocturnal oxygen therapy in hypoxemic chronic obstructive lung disease: a clinical trial. Ann. Intern. Med 93:391-398.
295. Connelly, K. G., and J. E. Repine. 1997. Markers for predicting the development of acute respiratory distress syndrome. Ann. Rev. Med. 48: 429-445.
296. Burney, P. 1995. The origins of obstructive airways disease: a role for diet? Am. J. Respir. Crit. Care Med. 151:1292-1293.